Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma
Abstract Background Esophagogastric junction adenocarcinoma (EJA) lacks serum biomarkers to assist in diagnosis and prognosis. Here, we aimed to evaluate the diagnostic and prognostic value of serum insulin-like growth factor binding protein 3 (IGFBP3) in EJA patients. Methods 320 participants were...
Main Authors: | Tian-Yan Ding, Yu-Hui Peng, Chao-Qun Hong, Bin-Liang Huang, Can-Tong Liu, Yun Luo, Ling-Yu Chu, Biao Zhang, Xin-Hao Li, Qi-Qi Qu, Yi-Wei Xu, Fang-Cai Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-11-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00591-1 |
Similar Items
-
Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene
by: LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun
Published: (2022-02-01) -
The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
by: Shuxing Wang, et al.
Published: (2021-10-01) -
Relationship between the number of dissected lymph node and the pathological staging in esophagogastric junction adenocarcinoma
by: Renwang Hu, et al.
Published: (2023-12-01) -
Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
by: Haitao Xu, et al.
Published: (2020-06-01) -
Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery
by: Zhenjiang Guo, et al.
Published: (2022-06-01)